TP53 and adrenal cortex carcinoma: Borges et al. reported that overexpression of AURKA occurs in pediatric ACC with the TP53 p.R337H variant [53], and that AMG900, an Aurora kinase inhibitor, acted synergistically with mitotane and doxorubicin in the inhibition of H295R cell proliferation [54].